Circadian redox oscillations and metabolism

Trends in Endocrinology and Metabolism

Volumn 26, Issue 8, 2015, Pages 430-437

  Milev, Nikolay B ^a   Reddy, Akhilesh B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Circadian rhythms; Metabolism; Peroxiredoxins; Redox oscillations

Indexed keywords

ADENOSINE TRIPHOSPHATE; CISPLATIN; DISULFIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PARACETAMOL; PEROXIDASE; PEROXIREDOXIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK;

AGING; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL METABOLISM; CIRCADIAN RHYTHM; COEVOLUTION; ERYTHROCYTE; FEEDBACK SYSTEM; HUMAN; LIVER CELL; LOCOMOTION; METABOLIC DISORDER; METABOLIC REGULATION; METABOLISM; NONHUMAN; OSCILLATION; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROSTATE CANCER; REPRESSOR GENE; REVIEW; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION REGULATION; ANIMAL; PHYSIOLOGY;

ANIMALS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; HUMANS; OXIDATION-REDUCTION; PEROXIREDOXINS;

EID: 84938288793     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.05.012     Document Type: Review

References (81)

1. Shea S.A., et al. Existence of an endogenous circadian blood pressure rhythm in humans that peaks in the evening. Circ. Res. 2011, 108:980-984.
2. Burioka N., et al. Circadian rhythms in the CNS and peripheral clock disorders: function of clock genes: influence of medication for bronchial asthma on circadian gene. J. Pharmacol. Sci. 2007, 103:144-149.
3. Smolensky M.H., et al. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv. Drug Deliv. Rev. 2007, 59:852-882.
4. Scheer F.A.J.L., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4453-4458.
5. Sigurdardottir L.G., et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol. Biomark. Prev. 2012, 21:1002-1011.
6. Libra M. Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review). Oncol. Rep. 2012, 28:418-428.
7. Balsalobre A., et al. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998, 93:929-937.
8. Duffield G.E., et al. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr. Biol. 2002, 12:551-557.
9. Nagoshi E.E., et al. Circadian gene expression in individual fibroblasts - cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004, 119:13.
10. Bass J. Circadian topology of metabolism. Nature 2012, 491:348-356.
11. O'Neill J.S., Reddy A.B. Circadian clocks in human red blood cells. Nature 2011, 469:498-503.
12. O'Neill J.S., et al. Circadian rhythms persist without transcription in a eukaryote. Nature 2011, 469:554-558.
13. Edgar R.S., et al. Peroxiredoxins are conserved markers of circadian rhythms. Nature 2012, 485:459-464.
14. Crowe S.A., et al. Atmospheric oxygenation three billion years ago. Nature 2013, 501:535-538.
15. Bass J., Takahashi J.S. Circadian integration of metabolism and energetics. Science 2010, 330:1349-1354.
16. Hara R., et al. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells 2001, 6:269-278.
17. Satoh Y. Time-restricted feeding entrains daily rhythms of energy metabolism in mice. Am. J. Regul. Integr. Comp. Physiol. 2005, 290:R1276-R1283.
18. Damiola F., et al. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000, 14:2950-2961.
19. Kohsaka A., et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007, 6:414-421.
20. Buxton O.M., et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci. Transl. Med. 2012, 4:129ra43.
21. + biosynthesis. Science 2009, 324:651-654.
22. + salvage pathway by CLOCK-SIRT1. Science 2009, 324:654-657.
23. + cycle drives mitochondrial oxidative metabolism in mice. Science 2013, 342:1243417.
24. + oscillation. Aging 2011, 3:794-802.
25. Asher G., et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134:317-328.
26. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
27. Rutter J. Regulation of Clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 2001, 293:510-514.
28. Dioum E.M. NPAS2: a gas-responsive transcription factor. Science 2002, 298:2385-2387.
29. Ishida M., et al. Effects of mutations in the heme domain on the transcriptional activity and DNA-binding activity of NPAS2. Biochem. Biophys. Res. Commun. 2008, 368:292-297.
30. Kaasik K., Lee C.C. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 2004, 430:467-471.
31. Yang J., et al. A novel heme-regulatory motif mediates heme-dependent degradation of the circadian factor period 2. Mol. Cell. Biol. 2008, 28:4697-4711.
32. Gupta N., Ragsdale S.W. Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor Rev-erbβ. J. Biol. Chem. 2011, 286:4392-4403.
33. Carter E.L., Ragsdale S.W. Modulation of nuclear receptor function by cellular redox poise. J. Inorg. Biochem. 2014, 133:92-103.
34. Nangle S.N., et al. Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex. Elife 2014, 3:e03674.
35. Schmalen I., et al. Interaction of circadian clock proteins CRY1 and PER2 is modulated by zinc binding and disulfide bond formation. Cell 2014, 157:1203-1215.
36. Okano S., et al. Unusual circadian locomotor activity and pathophysiology in mutant CRY1 transgenic mice. Neurosci. Lett. 2009, 451:246-251.
37. Lamia K.A., et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009, 326:437-440.
38. Shao D., et al. A redox-dependent mechanism for regulation of AMPK activation by thioredoxin1 during energy starvation. Cell Metab. 2014, 19:232-245.
39. Papp S.J., et al. DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. Elife 2015, 4:e04883.
40. Lee J-G., et al. Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells. Nat. Commun. 2013, 4:1568.
41. Hardeland R., et al. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol. Int. 2003, 20:921-962.
42. Luchetti F., et al. Melatonin signaling and cell protection function. FASEB J. 2010, 24:3603-3624.
43. Robinson J.L., et al. Circadian variation of liver metabolites and amino acids in rats adapted to a high protein, carbohydrate-free diet. J. Nutr. 1981, 111:1711-1720.
44. Kaminsky Y.G., et al. Analysis of the circadian rhythm in energy metabolism of rat liver. Int. J. Biochem. 1984, 16:629-639.
45. Isaacs J.T., Binkley F. Cyclic AMP-dependent control of the rat hepatic glutathione disulfide-sulfhydryl ratio. Biochim. Biophys. Acta 1977, 498:29-38.
46. Isaacs J., Binkley F. Glutathione dependent control of protein disulfide-sulfhydryl content by subcellular fractions of hepatic tissue. Biochim. Biophys. Acta 1977, 497:192-204.
47. Bélanger P.M., et al. Temporal variations in microsomal lipid peroxidation and in glutathione concentration of rat liver. Drug Metab. Dispos. 1991, 19:241-244.
48. Neuschwander-Tetri B.A., Rozin T. Diurnal variability of cysteine and glutathione content in the pancreas and liver of the mouse. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1996, 114:91-95.
49. Li X.M., et al. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice. Toxicol. Appl. Pharmacol. 1997, 143:281-290.
50. Pekovic-Vaughan V., et al. The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis. Genes Dev. 2014, 28:548-560.
51. Mori K., et al. Evaluation of hepatic damage by reactive metabolites - with consideration of circadian variation of murine hepatic glutathione levels. J. Toxicol. Sci. 2014, 39:537-544.
52. Xu Y-Q., et al. Diurnal variation of hepatic antioxidant gene expression in mice. PLoS ONE 2012, 7:e44237.
53. Tripathi D.N., Jena G.B. Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat. J. Pineal Res. 2010, 48:324-331.
54. Negi G., et al. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J. Pineal Res. 2011, 50:124-131.
55. Radha E., et al. Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb. Res. 1985, 40:823-831.
56. Scheer F.A.J.L., et al. The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS ONE 2011, 6:e24549.
57. Blanco R.A., et al. Diurnal variation in glutathione and cysteine redox states in human plasma. Am. J. Clin. Nutr. 2007, 86:1016-1023.
58. Wang T.A., et al. Circadian rhythm of redox state regulates excitability in suprachiasmatic nucleus neurons. Science 2012, 337:839-842.
59. Kondratov R.V. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev. 2006, 20:1868-1873.
60. Liu A.C., et al. Redundant function of REV-ERBα and β and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 2008, 4:e1000023.
61. Roumagnac P., et al. Evolutionary history of Salmonella Typhi. Science 2006, 314:1301-1304.
62. Cho C.S., et al. Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12043-12048.
63. Wood Z.A., et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28:32-40.
64. O'Neill J.S., Feeney K.A. Circadian redox and metabolic oscillations in mammalian systems. Antioxid. Redox Signal. 2013, 20:2966-2981.
65. Low F.M., et al. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid. Redox Signal. 2008, 10:1621-1630.
66. 2-dependent, reversible Inactivation of peroxiredoxin III in mitochondria. Mol. Cell 2012, 46:584-594.
67. Chang T-S., et al. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 2004, 279:50994-51001.
68. Zhang E.E., et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009, 139:199-210.
69. Wilking M., et al. Circadian rhythm connections to oxidative stress: implications for human health. Antioxid. Redox Signal. 2013, 19:192-208.
70. Froy O. Circadian rhythms, aging, and life span in mammals. Physiology 2011, 26:225-235.
71. Hurd M.W., Ralph M.R. The significance of circadian organization for longevity in the golden hamster. J. Biol. Rhythms 1998, 13:430-436.
72. Kondratov R.V., et al. Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging 2009, 1:979-987.
73. Froy O., Miskin R. Effect of feeding regimens on circadian rhythms: implications for aging and longevity. Aging 2010, 2:7-27.
74. Cantó C., Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol. Metab. 2009, 20:325-331.
75. Kelleher F.C., et al. Circadian molecular clocks and cancer. Cancer Lett. 2014, 342:9-18.
76. Acharya A., et al. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid. Med. Cell. Longev. 2010, 3:23-34.
77. Fu Z., Tindall D.J. FOXOs, cancer and regulation of apoptosis. Oncogene 2008, 27:2312-2319.
78. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
79. Park J., et al. 2-Cys peroxiredoxins: emerging hubs determining redox dependency of mammalian signaling networks. Int. J. Cell Biol. 2014, 2014:715867.
80. Rhee S.G., et al. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int. Suppl. 2007, 2007:S3-S8.
81. Yang K., et al. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 2002, 41:38029-38036.